We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00402766
Recruitment Status : Completed
First Posted : November 22, 2006
Last Update Posted : November 18, 2015
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2014
  Study Completion Date : February 2014